SAN
DIEGO, May 4, 2023 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, announced today the Company will
release its first quarter 2023 results on Wednesday, May 10, 2023, after the close of the
market.
NuVasive will hold a conference call on Wednesday, May
10, 2023, at 1:30 p.m. PT / 4:30 p.m. ET to discuss the
results of its financial performance for the first quarter of 2023.
The dial-in numbers are 1-877-300-8521 for domestic callers and
1-412-317-6026 for international callers. A live webcast of the
conference call and supplemental financial information of the
Company's first quarter 2023 results will be available on the
Investor Relations section of its website at www.nuvasive.com.
An audio replay of the call will be available until May 17, 2023. The replay dial-in numbers are
1-844-512-2921 for domestic callers and 1-412-317-6671 for
international callers. Please use pin number: 10178161. In
addition, the webcast will be archived on the Investor
Relations section of the Company's website.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is the leader in spine technology
innovation, with a mission to transform surgery, advance care, and
change lives. The Company's less-invasive, procedurally integrated
surgical solutions are designed to deliver reproducible and
clinically proven outcomes. The Company's comprehensive procedural
portfolio includes surgical access instruments, spinal implants,
fixation systems, biologics, software for surgical planning,
navigation and imaging solutions, magnetically adjustable implant
systems for spine and orthopedics, and intraoperative
neuromonitoring technology and service offerings. With more
than $1 billion in net sales, NuVasive operates
in more than 50 countries serving surgeons, hospitals, and
patients. For more information, please
visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements
included in this news release and the associated conference call
and webcast that are not a description of historical facts are
forward-looking statements that involve risks, uncertainties,
assumptions and other factors which, if they do not materialize or
prove correct, could cause NuVasive's results to differ
materially from historical results or those expressed or implied by
such forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, but are not limited to, the risk
that NuVasive's net sales or earnings projections may
turn out to be inaccurate because of the preliminary nature of the
forecasts; the risk of further adjustment to financial results or
future financial expectations; unanticipated difficulty in selling
products, generating net sales or producing expected profitability;
and those other risks and uncertainties more fully described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available
at www.sec.gov. NuVasive assumes no obligation to
update any forward-looking statement to reflect events or
circumstances arising after the date on which it was made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-announces-conference-call-and-webcast-of-first-quarter-2023-results-301815639.html
SOURCE NuVasive, Inc.